REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX)

Historical Holders from Q3 2015 to Q3 2025

Symbol
RGNX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
51.1M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
41.4M
Holdings value
$399M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
166
Number of buys
84
Number of sells
-67
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Redmile Group, LLC 9.9% $43.9M 5.06M Redmile Group, LLC 30 Jun 2025
JPMORGAN CHASE & CO 7.4% $34.8M 3.7M JPMORGAN CHASE & CO. 31 Dec 2024
BlackRock, Inc. 7.3% -33.6% $34.6M -$16.8M 3.68M -32.7% BlackRock, Inc. 31 Mar 2025
BlackRock Portfolio Management LLC 6.2% $25.7M 3.13M BlackRock Portfolio Management LLC 30 Jun 2025
VANGUARD GROUP INC 6.02% $28.1M 2.99M The Vanguard Group 31 Dec 2024
STATE STREET CORP 4.4% $20.6M 2.19M STATE STREET CORPORATION 31 Dec 2024

Institutional Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 41.4M $399M -$3.67M $9.65 166
2025 Q2 42M $345M +$5.51M $8.21 159
2025 Q1 41.7M $298M -$1.5M $7.15 163
2024 Q4 42.1M $325M -$15.5M $7.73 175
2024 Q3 43.7M $458M -$8.52M $10.49 184
2024 Q2 43.8M $512M +$5.42M $11.70 180
2024 Q1 42.5M $896M +$95.8M $21.07 185
2023 Q4 38.1M $684M +$18.8M $17.95 167
2023 Q3 37.1M $610M -$2.25M $16.46 157
2023 Q2 37.1M $742M +$3.96M $19.99 165
2023 Q1 37M $700M +$18.8M $18.91 170
2022 Q4 35.7M $810M +$5.38M $22.68 180
2022 Q3 35.1M $927M -$30.5M $26.43 173
2022 Q2 36.2M $893M +$28.9M $24.70 157
2022 Q1 34.9M $1.16B -$21M $33.19 181
2021 Q4 35.5M $1.16B +$58.4M $32.70 168
2021 Q3 33.4M $1.4B -$3.05M $41.92 177
2021 Q2 33.5M $1.3B +$26.8M $38.85 168
2021 Q1 32.9M $1.12B +$188M $34.11 178
2020 Q4 27.3M $1.24B -$41.7M $45.36 182
2020 Q3 28.5M $785M -$29.7M $27.52 162
2020 Q2 29.4M $1.08B +$20M $36.83 174
2020 Q1 28.9M $937M -$29.1M $32.38 160
2019 Q4 29.6M $1.21B -$13.2M $40.97 178
2019 Q3 29.2M $1.04B -$21.9M $35.60 165
2019 Q2 29.4M $1.51B -$22.8M $51.37 184
2019 Q1 30.1M $1.73B +$15.6M $57.31 206
2018 Q4 29.9M $1.26B +$31.7M $41.95 178
2018 Q3 28.5M $2.15B +$194M $75.50 198
2018 Q2 26M $1.87B +$332M $71.75 174
2018 Q1 22.4M $668M +$29.3M $29.85 118
2017 Q4 21.6M $718M +$5.11M $33.25 106
2017 Q3 21.4M $704M -$14.4M $32.95 87
2017 Q2 22.7M $448M +$37.3M $19.75 86
2017 Q1 20.8M $401M +$94.9M $19.30 86
2016 Q4 18.3M $339M +$28.4M $18.55 77
2016 Q3 16.9M $237M +$3.1M $14.01 71
2016 Q2 17.9M $144M +$9.89M $8.00 67
2016 Q1 16.6M $180M +$4.02M $10.80 62
2015 Q4 15M $247M -$9.9M $16.60 65
2015 Q3 14.3M $310M +$310M $22.03 47